All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan
Tài liệu tham khảo
El Nahas, 2005, Chronic kidney disease: the global challenge, Lancet, 365, 331, 10.1016/S0140-6736(05)17789-7
Coresh, 2007, Prevalence of chronic kidney disease in the United States, JAMA, 298, 2038, 10.1001/jama.298.17.2038
Couser, 2007, Chronic kidney disease—the promise and the perils, J Am Soc Nephrol, 18, 2803, 10.1681/ASN.2007080964
Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031
Weiner, 2004, Chronic kidney disease as a risk factor for cardiovascular disease an all-cause mortality: a pooled analysis of community-based studies, J Am Soc Nephrol, 15, 1307, 10.1097/01.ASN.0000123691.46138.E2
Shlipak, 2005, Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors, JAMA, 293, 1737, 10.1001/jama.293.14.1737
Fried, 2005, Kidney function as a predictor of non-cardiovascular mortality, J Am Soc Nephrol, 16, 3728, 10.1681/ASN.2005040384
Raymond, 2007, Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age, Nephrol Dial Transplant, 22, 3214, 10.1093/ndt/gfm396
Jorgensen, 2008, Association of albuminuria and cancer incidence, J Am Soc Nephrol, 19, 992, 10.1681/ASN.2007060712
Nickolas, 2004, Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000, Am J Kidney Dis, 44, 185, 10.1053/j.ajkd.2004.04.023
Coresh, 2005, Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000, J Am Soc Nephrol, 16, 180, 10.1681/ASN.2004070539
Hsu, 2006, High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey, Am J Kidney Dis, 48, 727, 10.1053/j.ajkd.2006.07.018
2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification, Am J Kidney Dis, 39, s1
Jafar, 2001, Angiotensin-converting enzyme inhibitors and progression of non-diabetic renal disease, Ann Intern Med, 135, 73, 10.7326/0003-4819-135-2-200107170-00007
Myers, 2006, Recommendations for improving serum creatinine measurement: a report from the laboratory working group of the national kidney disease education program, Clin Chem, 52, 5, 10.1373/clinchem.2005.0525144
Roche
Wu, 2001, Prevalence and clustering of cardiovascular risk factors among healthy adults in a Chinese population: the MJ Health Screening Center Study in Taiwan, Int J Obes, 25, 1189, 10.1038/sj.ijo.0801679
Cheng, 2005, Reducing health disparity in Taiwan: quantifying the role of smoking, Tob Control, 14, i23, 10.1136/tc.2003.005546
Hosmer, 2008, 392
2002, Annual smoking—attributable mortality, years of potential life lost, and economic costs—United States, 1995–1999, MMWR Morb Mortal Wkly Rep, 51, 300
Wen, 2005, Smoking attributable mortality for Taiwan and its projection to 2020 under different smoking scenarios, Tob Control, 14, i76, 10.1136/tc.2004.007955
Flegal, 2005, Excess deaths associated with underweight, overweight, and obesity, JAMA, 293, 1861, 10.1001/jama.293.15.1861
Merkin, 2007, Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: the cardiovascular health study, Soc Sci Med, 65, 809, 10.1016/j.socscimed.2007.04.011
Shoham, 2007, Kidney disease in life-course socioeconomic context: the atherosclerosis risk in communities (ARIC) study, Am J Kidney Dis, 49, 217, 10.1053/j.ajkd.2006.11.031
Wen, 2008, A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity, Ann Intern Med, 148, 258, 10.7326/0003-4819-148-4-200802190-00004
Wen, 2005, Smoking behavior in Taiwan, 2001, Tob Control, 14, i51, 10.1136/tc.2004.008011
Coresh, 2003, Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey, Am J Kidney Dis, 41, 1, 10.1053/ajkd.2003.50007
Arnlov, 2005, Low-grade albuminuria and incidence of cardiovascular disease events in non-hypertensive and non-diabetic individuals The Framingham Heart Study, Circulation, 112, 969, 10.1161/CIRCULATIONAHA.105.538132
Hillege, 2002, Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in general population, Circulation, 106, 1777, 10.1161/01.CIR.0000031732.78052.81
Hallan, 2007, Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals, Arch Intern Med, 167, 2490, 10.1001/archinte.167.22.2490
Stevens, 2007, Pathogenesis and treatment of kidney disease: Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database, Am J Kidney Dis, 50, 21, 10.1053/j.ajkd.2007.04.004
Coresh, 2002, Letter to the editor: estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration, J Am Soc Nephrol, 13, 2811, 10.1097/01.ASN.0000037420.89149.C9
Cosyns, 2003, Aristolochic acid and “Chinese herbs nephropathy”: a review of the evidence to date, Drug Safety, 26, 33, 10.2165/00002018-200326010-00004
Wojcikowski, 2004, Medicinal herbal extracts-renal friend or foe? Part one: the toxicities of medicinal herbs, Nephrology, 9, 313, 10.1111/j.1440-1797.2004.00310.x